Wave Stocks Cut in Half on Higher Dose Obesity Data
Science of Life Waves improved body composition touted in the study of early stage obesity therapy RNA interference his investigation-but when it comes to the higher 400-mg dose, analysts are not impressed. At $5.59 apiece when the opening bell rang on Thursday, the biotech was trading 54% lower than its previous closing price. Oppenheimer analyst … Read more